Valeo Pharma appoints Kyle Steiger to role of Senior Vice-President and CEO
Valeo Pharma is a pharmaceutical company dedicated to the commercialisation of innovative prescription products in Canada, with a focus on respirology/allergy, opthamology, and other products.
Kyle Steiger is a pharmaceutical industry veteran whose work experience includes specialty pharma, biologics, primary care, medical devices, over-the-counter, health policy, and market access. He spent nearly 20 years at Novartis Canada in various executive positions, including franchise Head of Hematology, Vice President of Primary Care, and most recently, Vice President of Opthamology.
Karl Steiger said, “We have the right set of innovative products, the right team of people and appropriate corporate structure to deliver on our ambitious corporate objectives. I am thrilled to be joining the company at such an exciting time, and look forward to help accelerating our growth, profitability, and industry leadership ambitions.”